Subscribe To
Syneos health schedules fourth quarter and full year 2021 earnings call for thursday, february 17th, 2022
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated bio...
February 1, 2022, 7:26 am
Syneos health schedules fourth quarter and full year 2021 earnings call for thursday, february 17th, 2022
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated bio...
February 1, 2022, 7:26 am
Syneos health schedules fourth quarter and full year 2021 earnings call for thursday, february 17th, 2022
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated bio...
February 1, 2022, 7:26 am
Down 30% in a month, is there more pain for chemocentryx stock?
The stock price of ChemoCentryx, a biopharmaceuticals company focused on orally-administered therapeuti...
February 1, 2022, 6:00 am
Down 30% in a month, is there more pain for chemocentryx stock?
The stock price of ChemoCentryx, a biopharmaceuticals company focused on orally-administered therapeuti...
February 1, 2022, 6:00 am
Down 30% in a month, is there more pain for chemocentryx stock?
The stock price of ChemoCentryx, a biopharmaceuticals company focused on orally-administered therapeuti...
February 1, 2022, 6:00 am
West pharmaceutical services (wst) gains but lags market: what you should know
In the latest trading session, West pharmaceutical Services (WST) closed at $393.22, marking a +0.05% m...
January 31, 2022, 7:59 pm
West pharmaceutical services (wst) gains but lags market: what you should know
In the latest trading session, West pharmaceutical Services (WST) closed at $393.22, marking a +0.05% m...
January 31, 2022, 7:59 pm
West pharmaceutical services (wst) gains but lags market: what you should know
In the latest trading session, West pharmaceutical Services (WST) closed at $393.22, marking a +0.05% m...
January 31, 2022, 7:59 pm
Esperion therapeutics' future hinges on a clinical trial
Esperion Therapeutics Inc. ( ESPR , Financial) calls itself the "Lipid Management Company," a pharmaceutical...
January 31, 2022, 3:31 pm
Esperion therapeutics' future hinges on a clinical trial
Esperion Therapeutics Inc. ( ESPR , Financial) calls itself the "Lipid Management Company," a pharmaceutical...
January 31, 2022, 3:31 pm
Esperion therapeutics' future hinges on a clinical trial
Esperion Therapeutics Inc. ( ESPR , Financial) calls itself the "Lipid Management Company," a pharmaceutical...
January 31, 2022, 3:31 pm
Cardinal health (cah) to post q2 earnings: what's in store?
Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the pharmaceu...
January 31, 2022, 1:06 pm
Cardinal health (cah) to post q2 earnings: what's in store?
Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the pharmaceu...
January 31, 2022, 1:06 pm
Cardinal health (cah) to post q2 earnings: what's in store?
Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the pharmaceu...
January 31, 2022, 1:06 pm
Fda approves takeda's vonvendi as prophylactic treatment in bleeding disorder
The FDA has approved Takeda pharmaceutical Co Ltd's TAK Vonvendi [von Willebrand factor (Recombinant...
January 31, 2022, 12:27 pm
Fda approves takeda's vonvendi as prophylactic treatment in bleeding disorder
The FDA has approved Takeda pharmaceutical Co Ltd's TAK Vonvendi [von Willebrand factor (Recombinant...
January 31, 2022, 12:27 pm
Fda approves takeda's vonvendi as prophylactic treatment in bleeding disorder
The FDA has approved Takeda pharmaceutical Co Ltd's TAK Vonvendi [von Willebrand factor (Recombinant...
January 31, 2022, 12:27 pm
Why madrigal pharmaceuticals stock briefly spiked today
A positive data readout from a phase 3 clinical trial propelled the drugmaker's shares higher....
January 31, 2022, 12:25 pm
Why madrigal pharmaceuticals stock briefly spiked today
A positive data readout from a phase 3 clinical trial propelled the drugmaker's shares higher....
January 31, 2022, 12:25 pm